Membership

Thank you for choosing to amplify your career journey and invest in your professional and personal development by joining Health Industry Hub‘s Pharma, MedTech and Biotech industry network.

With over 56,000 industry professionals who have accessed the Health Industry Hub content in 2021, we trust that you will also find immense value in the latest industry news, market dynamics and trends, scientific and innovation insights, and professional development content including our Women in Leadership series, collection of DE&I content and our Digital Acceleration Roundtable series to ignite in you the most powerful version of yourself.

  • New registrations: Register to enjoy the 14 days FREE trial with full access to the latest Pharma, MedTech and Biotech news and professional development content. No credit card is required. After the trial period, please subscribe to an annual or monthly subscription – link below.
  • Corporate subscriptions: Please contact us for a quote that meets the needs of your organisation. Tiered pricing benefits apply.
  • Existing registrations with expired access: Please subscribe to an annual or monthly subscription – link below.

The content is copyright protected and access is granted under individual licenses. Please note subscription terms of use.

Human Resources

PAIG co-chairs reflect on industry progress in D&I with sights set on next phase goals

Health Industry Hub | January 17, 2022 |

Human Resources: In this Health Industry Hub podcast, Medicines Australia’s PAIG (Pharma Australia Inclusion Group) co-chairs reflect on their contribution […]

More


News & Trends - Medical Technology

MedTech News -

Stryker announces fellowships for medtech partner projects

Health Industry Hub | January 17, 2022 |

MedTech News: Stryker announced two of its partner research projects have secured fellowship funding from the Australian government’s Researcher Exchange […]

More


News & Trends - Pharmaceuticals

Pharma News - New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

Health Industry Hub | January 17, 2022 |

Pharma News: Update to international guidelines recommend two new drugs for the treatment of COVID-19. Eli Lilly’s oral JAK inhibitor, […]

More


News & Trends - Pharmaceuticals

Pharma News -

Novartis shifts focus as CAR T-cell therapy fails to add benefit in non-Hodgkin lymphoma

Health Industry Hub | January 17, 2022 |

Pharma News: Novartis’ chimeric antigen receptor (CAR) T-cell therapy was not found to improve event-free survival over what was seen […]

More